Vyome Holdings, Inc. Common Stock (HIND)

Price$2.16

Value ScoreC

Growth ScoreF

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-66.23%

Price vs S&P 500 (4W)4.86%

VGM Score24.18

Market Capitalization$15.16M

All Metrics

Book Value / Share (Quarterly)$0.96

P/TBV (Annual)9.13x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-69.47%

Cash Flow / Share (Quarterly)$-0.44

Price vs S&P 500 (YTD)-45.37%

Gross Margin (TTM)48.76%

Net Profit Margin (TTM)-985.46%

EPS (TTM)$-12.41

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-12.41

Revenue Growth (5Y)-27.44%

EPS (Annual)$-4.75

ROI (Annual)-420.22%

Gross Margin (Annual)68.43%

Net Profit Margin (5Y Avg)-861.11%

Cash / Share (Quarterly)$1.25

Revenue Growth QoQ (YoY)-97.16%

ROA (Last FY)-157.95%

Revenue Growth TTM (YoY)-81.26%

EBITD / Share (TTM)$-3.53

ROE (5Y Avg)-452.03%

Operating Margin (TTM)-1027.78%

Cash Flow / Share (Annual)$-0.63

P/B Ratio2.25x

P/B Ratio (Quarterly)2.24x

Net Income / Employee (Annual)$-1,140,200

EV / Revenue (TTM)4.73x

Net Interest Coverage (TTM)-89.22x

ROA (TTM)-161.83%

EPS Incl Extra (Annual)$-4.75

Current Ratio (Annual)1.99x

Quick Ratio (Quarterly)4.17x

3-Month Avg Trading Volume0.11M

52-Week Price Return-87.29%

Revenue / Employee (TTM)$149,400

Tangible BV / Share (Quarterly)$0.92

P/S Ratio (Annual)47.42x

Asset Turnover (Annual)0.05x

52-Week High$20.76

Operating Margin (5Y Avg)-878.19%

EPS Excl Extra (Annual)$-4.75

26-Week Price Return-58.30%

Quick Ratio (Annual)1.86x

13-Week Price Return-25.77%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.27x

Enterprise Value$6.36M

Revenue / Share Growth (5Y)-73.32%

Asset Turnover (TTM)0.16x

Revenue / Employee (Annual)$35,500

Inventory Turnover (Annual)0.95x

Pretax Margin (Annual)-3277.25%

Cash / Share (Annual)$0.84

3-Month Return Std Dev60.18%

Gross Margin (5Y Avg)63.49%

Net Income / Employee (TTM)$-1,472,500

ROE (Last FY)-420.22%

Net Interest Coverage (Annual)-281.90x

EPS Basic Excl Extra (Annual)$-4.75

Receivables Turnover (TTM)3.66x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-12.41

Receivables Turnover (Annual)0.65x

ROI (TTM)-302.13%

P/S Ratio (TTM)11.27x

Pretax Margin (5Y Avg)-875.45%

Revenue / Share (Annual)$0.15

Tangible BV / Share (Annual)$0.36

Price vs S&P 500 (52W)-111.66%

Year-to-Date Return-37.21%

5-Day Price Return-6.90%

EPS Normalized (Annual)$-4.75

ROA (5Y Avg)-189.71%

Net Profit Margin (Annual)-3209.79%

Month-to-Date Return-7.69%

EBITD / Share (Annual)$-4.83

Operating Margin (Annual)-3269.39%

LT Debt / Equity (Annual)0.09x

ROI (5Y Avg)-447.58%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-12.41

P/TBV (Quarterly)2.35x

P/B Ratio (Annual)7.95x

Inventory Turnover (TTM)0.83x

Pretax Margin (TTM)-1002.59%

Book Value / Share (Annual)$0.41

Price vs S&P 500 (13W)-34.03%

Beta1.55x

Revenue / Share (TTM)$0.20

ROE (TTM)-302.13%

52-Week Low$1.75

vGradeC

gGradeF

mGradeF

vgmGradeD

Show chart for

Earnings Surprise History

Q1 26-0.15est. -0.18

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.14

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
HINDVyome Holdings, Inc. Common Stock	C	F	F	$2.16
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Vyome Holdings Inc operates as a biotechnology and pharmaceutical company with two core segments. The company manufactures and distributes antifungal pharmaceutical products while advancing a pipeline of novel biotech therapies (VT-1953, VT-1908, and VB-1953) in development.